Evidence map›Paper›PMID 42559296›Full record

ArticleEngineering biology

Engineering Biology in an Age of Convergence: Evolving Research Leadership at the AI-SynBio-Robotics Frontier.

Ross K J McLennan, Richard Kitney, Isak S Pretorius

Abstract read
In one paragraph

Article in Engineering biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ross K J McLennanAustralian Research Council Centre of Excellence in Synthetic Biology Macquarie University Sydney New South Wales Australia.ORCID https://orcid.org/0009-0009-7108-5279
Richard KitneyDepartment of Bioengineering Imperial College London London UK.ORCID https://orcid.org/0000-0002-6499-5209
Isak S PretoriusAustralian Research Council Centre of Excellence in Synthetic Biology Macquarie University Sydney New South Wales Australia.ORCID https://orcid.org/0000-0001-9127-3175

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI), engineering biology (often called synthetic biology), automation, and RNA therapeutics are rapidly converging into integrated discovery and translation platforms in which computational design, automated experimentation, and biological implementation are tightly coupled. This convergence is accelerating scientific capability and translational potential, but it also compounds governance complexity across biosecurity, data and AI governance, research integrity, national interest, social licence, and funding accountability. Conventional, discipline-based and compliance-centred oversight models are poorly suited to these integrated systems. This

Indexed as

genetic engineeringgenome engineeringmicrobial engineeringmicrobial synthesissynthetic biology

Identifiers

PMID42559296
PMCPMC13439627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.